Skip to content
WeighLab

Zeuss vs Blue Sky MD

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Zeuss

Provider comparison

Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription.

Semaglutide / month
$99/moSold as a $198 60-day supply, compounded, no subscription
Tirzepatide / month
$169/moSold as a $338 60-day supply, compounded, no subscription
Index 66/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Zeuss pricing Read review

Blue Sky MD

Provider comparison

North Carolina residents who want an established, physician-led, LegitScript-certified in-person clinic.

Semaglutide / month
$173.33/moEquivalent (weekly starting rate, in-office, compounded)
Tirzepatide / month
$260/moEquivalent (weekly starting rate, in-office, compounded)
Index 66/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Blue Sky MD pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 66/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Zeuss
Coverage not published
Blue Sky MD
1 state

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Zeuss

Blue Sky MD

Semaglutide / month
Zeuss: $99/moSold as a $198 60-day supply, compounded, no subscription
Blue Sky MD: $173.33/moEquivalent (weekly starting rate, in-office, compounded)
Tirzepatide / month
Zeuss: $169/moSold as a $338 60-day supply, compounded, no subscription
Blue Sky MD: $260/moEquivalent (weekly starting rate, in-office, compounded)
Semaglutide / year (modeled)
Zeuss: $1,188
Blue Sky MD: $2,080
Tirzepatide / year (modeled)
Zeuss: $2,028
Blue Sky MD: $3,120
State availability
Zeuss: Coverage not published
Blue Sky MD: 1 state
Oral / sublingual option listed
Zeuss: Not listed
Blue Sky MD: Not listed
Brand-name access listed
Zeuss: Not confirmed
Blue Sky MD: Yes
Provider facts checked
Zeuss: October 2026
Blue Sky MD: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Zeuss

Patients already stable on a maintenance GLP-1 dose who want to pay per fill instead of a subscription.

Reasons to consider it

  • No subscription: its own FAQ says 'no recurring charges or automatic refills', so you pay per order
  • LegitScript certified, with the badge and verification link displayed on the homepage
  • States it 'partners exclusively with 503A and 503B state-licensed compounding pharmacies'

What to weigh up

  • Sold only as a 60-day supply ($198 semaglutide, $338 tirzepatide), and the site doesn't say whether the price changes at higher doses
  • Compounded drugs only; no brand-name Wegovy or Zepbound
  • No compounding pharmacy is named, only 'licensed partner pharmacy'

Regulatory note: the FDA issued a warning letter to Zeuss LLC dba Zeuss in February 2026. We still list and link to Zeuss; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check Zeuss pricing Read the full Zeuss review

Blue Sky MD

North Carolina residents who want an established, physician-led, LegitScript-certified in-person clinic.

Reasons to consider it

  • Names medical director Dr. David LaMond and displays LegitScript certification
  • Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro as well as compounded options
  • Publishes weekly starting prices for in-office compounded treatment

What to weigh up

  • The published $40/$60 per-week price is explicitly labeled 'in-office' on the GLP-1 page, and that specific page never mentions telehealth at all — whether the rate applies to out-of-state or telehealth-only patients is unconfirmed
  • Geographic footprint is North Carolina only; no state-by-state telehealth coverage list is published
  • No compounding pharmacy is named anywhere on the site

Compounded drugs are not FDA-approved. Understand the medication options.

Check Blue Sky MD pricing Read the full Blue Sky MD review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

ZeussBlue Sky MD
Normalized Cost/Month
Zeuss:
89/100
Blue Sky MD:
60/100
Price Transparency
Zeuss:
86/100
Blue Sky MD:
78/100
Nationwide Access
Zeuss:
24/100
Blue Sky MD:
42/100
Formulation Options
Zeuss:
66/100
Blue Sky MD:
79/100
Clinical Oversight
Zeuss:
52/100
Blue Sky MD:
87/100
Contract Flexibility
Zeuss:
61/100
Blue Sky MD:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to ZeussAlternatives to Blue Sky MD
More provider matchups
CoreAge Rx vs ZeussCoreAge Rx vs Blue Sky MD
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.